Ledger.Open graph →
SEC Form D · Amendment · filed December 11, 2013

Seldar Pharma, Inc

Offering
$13.0M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jeffrey Bird · Palo Alto, CADirectorDonna L. Tempel · Bridgewater, NJExec · Director · PromoterChristopher Del Mastro · Bridgewater, NJExecArnold Oronsky · Menlo Park, CADirectorRobert Desjardins · Bridgewater, NJExec · Director · PromoterRobert D. Basham · TAMPA, FLExec · Director · PromoterJoseph F. Scoby · Chicago, ILExec · Director · PromoterPhilip F. Grigus · Chicago, ILExecBardwell C. Salmon · Littleton, MADirectorJohn E. Niemoller · Littleton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗